Calendar

pharmadog

Week of Mar 2, 2026

Mar 5, 2026approval178d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Mar 5, 2026approval178d agoERLEADA (APALUTAMIDE) — FDA approvalapalutamide

Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

full page →apalutamide →fda approvals ↗

Mar 5, 2026approval178d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

Sponsor: ANNORA PHARMA. Form: SUSPENSION. Route: ORAL

full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗

Mar 6, 2026approval177d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval177d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION

full page →risankizumab →fda approvals ↗

Mar 6, 2026approval177d agoQUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval177d agoPYLARIFY TRUVU (PIFLUFOLASTAT F-18) — FDA approval

Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 6, 2026approval177d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval177d agoQSYMIA (PHENTERMINE HYDROCHLORIDE) — FDA approval(phentermine hydrochloride + topiramate) ER

Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →(phentermine hydrochloride + topiramate) ER →fda approvals ↗

Mar 6, 2026approval177d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval177d agoXELJANZ XR (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Mar 6, 2026approval177d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval177d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval177d agoVITAMIN K1 (PHYTONADIONE) — FDA approvalPHYTONADIONE

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗

Mar 6, 2026approval177d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval177d agoSIPONIMOD — FDA approvalSIPONIMOD

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →SIPONIMOD →fda approvals ↗

Mar 6, 2026approval177d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Mar 6, 2026approval177d agoSOTYKTU (DEUCRAVACITINIB) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval177d agoTROKENDI XR (TOPIRAMATE) — FDA approvalSUPERNUS PHARMACEUTICALS, INC.

Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Mar 6, 2026approval177d agoNICARDIPINE HYDROCHLORIDE — FDA approvalNICARDIPINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →NICARDIPINE HYDROCHLORIDE →fda approvals ↗

Mar 6, 2026approval177d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: PRINSTON INC. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Mar 6, 2026approval177d agoEVEROLIMUS — FDA approvalEVEROLIMUS

Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

full page →EVEROLIMUS →fda approvals ↗

Mar 6, 2026approval177d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

full page →Restasis →fda approvals ↗

Mar 6, 2026approval177d agoEPRONTIA (TOPIRAMATE) — FDA approvaltopiramate ER

Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

full page →topiramate ER →fda approvals ↗

Mar 6, 2026approval177d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

full page →Restasis →fda approvals ↗

Mar 6, 2026approval177d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvaltofacitinib citrate ER

Sponsor: PFIZER. Form: SOLUTION. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Week of Mar 9, 2026

Mar 9, 2026approval174d agoOXCARBAZEPINE — FDA approvalRiconpharma LLC

Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Mar 9, 2026approval

← prev

page 391 of 403

Week of Mar 2, 2026

Week of Mar 9, 2026